The call for abstracts will cover the thematic sessions of the three tracks:

  1. Research
  2. Person-centred care
  3. Advocacy and policy change

Below you will find a non-extensive list of topics of interest:

  • Signs and symptoms of ILD and/or IPF
  • Pharmacological treatment for ILD and/or IPF
  • Non-pharmacological treatment for ILD and/or IPF
  • Clinical trials for ILD and/or IPF
  • Insights into anti-fibrotic drugs for ILD and/or IPF
  • Genotype and phenotype of ILD and/or IPF
  • Self-management for ILD and/or IPF
  • Multi-disciplinary approaches for ILD and/or IPF care
  • Lung transplantation for ILD and/or IPF care
  • Palliative care for ILD and/or IPF
  • Role of pulmonary rehabilitation in IPF and/or ILD care
  • Improving access to care for ILD and/or IPF patients
  • Role of patient groups in the field of ILD and/or IPF
  • Advocacy activities in field of ILD and/or IPF
  • Policy efforts in the field of ILD and/or IPF
  • Involvement of patients within the patient care pathway
  • Awareness raising activities in the field of ILD and/or IPF

Abstracts that are approved will exhibit a poster during the European IPF Patient Summit 2020.